Population pharmacokinetics of efavirenz in HIV and TB/HIV coinfected children: the significance of genotype-guided dosing

OBJECTIVES: The current WHO weight-based dosing recommendations for efavirenz result in a wide variability of drug exposure in children. Our objectives are to characterize the effects of rifampicin- and isoniazid-containing anti-TB therapy and CYP2B6 activity on efavirenz concentrations in children,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Antimicrob Chemother
Autori principali: Alghamdi, Wael A, Antwi, Sampson, Enimil, Anthony, Yang, Hongmei, Dompreh, Albert, Wiesner, Lubbe, Langaee, Taimour, Peloquin, Charles A, Kwara, Awewura
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6736323/
https://ncbi.nlm.nih.gov/pubmed/31243456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz238
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi